NLRP3-Dependent Pyroptosis: A Candidate Therapeutic Target for Depression

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Depression is a significant global health and economic burden.
• Neuroinflammation is increasingly recognized as a crucial factor in depression development.
• Pyroptosis, a pro-inflammatory programmed cell death, is implicated in neurological and inflammatory diseases.

Purpose of the Study:

• To review recent findings on pyroptosis activation and regulation in depression.
• To highlight the role of neuroinflammation and pyroptosis in depression pathogenesis.
• To explore therapeutic strategies targeting pyroptosis for depression.

Main Methods:

• Literature review of studies on pyroptosis, neuroinflammation, and depression.
• Analysis of the role of Gasdermin (GSDM) mediated pyroptosis.
• Examination of the involvement of the NLRP3 inflammasome in depression-related neuroinflammation.

Main Results:

• Depression is closely linked to pyroptosis and neuroinflammation in brain regions like the hippocampus and amygdala.
• The nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome plays a critical role.
• Modulating pyroptosis via chemical agents and natural products shows therapeutic promise.

Conclusions:

• Pyroptosis is an important pathological mechanism in depression.
• Targeting pyroptosis and associated neuroinflammation presents a potential therapeutic avenue for depression.
• Further research into pyroptosis regulation is crucial for developing novel depression treatments.